Diabetes Leadership Council and Insulet Corporation Announce Launch of Multiyear Effort to Protect Access to Healthcare for People with Diabetes
Through its Patient Safety Net Protection Collaborative, DLC calls for organizations to protect the patient safety net for diabetes patients
WASHINGTON, Nov. 17, 2026 /PRNewswire/ -- The Diabetes Leadership Council (DLC) and Insulet Corporation, the global leader in tubeless insulin pump technology today announced the launch of the Patient Safety Net Protection (PSNP) Collaborative, which aims to help the diabetes community prepare for anticipated health coverage disruptions stemming from recent federal policy changes.
Approximately 11% of the U.S. population lives with diabetes, and estimates show more than 1 million of these individuals could lose their healthcare coverage starting in January and in the years ahead due to expected Medicaid cuts and the expiration of Affordable Care Act (ACA) subsidies. Because diabetes management requires continuous access to medications, medical supplies, medical devices and routine care, interruptions in health coverage can have immediate consequences for diabetes patients.
Over the coming years, the PSNP Collaborative will work to protect access to medications, supplies and medical care for uninsured or underinsured people living with diabetes by assessing emerging risks, connecting patients with existing resources, advancing policy solutions, and uniting stakeholders to protect access to coverage and care. In its initial phase, a PSNP task force representing 18 diabetes community groups, health policy experts, academic researchers, and other leaders in diabetes will be established.
"No single organization can address these challenges alone," said George Huntley, CEO of the Diabetes Leadership Council (DLC) and Diabetes Patient Advocacy Coalition (DPAC). "The diabetes community needs to prepare now for the challenges patients may face in the years ahead. This collaborative is about creating a coordinated response across the diabetes community and making sure patient needs remain at the center of policy decisions."
"As the healthcare landscape continues to evolve, access to diabetes care and technology remains essential," said Dr. Trang Ly, Senior Vice President, Chief Medical Officer, Insulet Corporation. "People with diabetes deserve the tools that help them manage their condition, reduce the daily burden of diabetes, and improve health outcomes. Insulet is proud to support the Diabetes Leadership Council's efforts to help remove barriers to healthcare and ensure that people with diabetes remain at the center of healthcare policy discussions during this period of change."
Working with Task Force members, the PSNP Collaborative will conduct a national analysis to identify patient populations and regions most at risk of coverage disruptions, evaluate options to help patients maintain access to care and develop communications strategies to connect vulnerable patients with available resources. DLC is excited to work with the diabetes community to amplify the patient voice on behalf of those most in need.
About the Diabetes Leadership Council
The Diabetes Leadership Council (DLC) is a 501(c)(3) patient advocacy organization comprised of experienced leaders in the diabetes community. Our members - all former leaders of national diabetes organizations - are committed to securing effective, affordable health care and a discrimination-free environment for every person affected by diabetes through sound policy initiatives at the federal and state levels. EIN #46-3571905.
Media Contact:
[email protected]
SOURCE Diabetes Leadership Council



Share this article